Entry price: 138.03
Fundamentals:
- Sector: Medical - Biotech
- EPS % Chg (Last Qtr): 44%
- EPS % Chg (Previous Qtr): 27%
- 3 Year EPS Growth Rate: 0%
- EPS Est % Chg (Current Yr): 0%
- Sales % Chg (Last Qtr): 106%
- Sales % Chg (Previous Qtr): 56%
- 3-Year Sales Growth Rate: 101%
- Annual Pre -Tax Margin: -129.9%